Neuroprotective TRPC6 vs. potentially synaptotoxic TRPC3 upon upregulation. A TRPC6 deficiency or increased activity due to gain-of-function mutations has been associated with a multitude of diseases, such as kidney disease, pulmonary disease, and neurological disease [78]. This evidence concerns the gene TRPC3 and lung disorder.